1Matsusaka T, Katori H, Inagami T, et al. Communication between myocytes and f Marshall RP, McAnulty RJ,Laurent GJ. Angiotvnsin Ⅱ is mitogenic for human lung fibroblasts via activation of the type 1 receptor. Am J Respir Crit Care Med ,2000 ,161:1999-1004.
2Nakao A, Hasehawa Y, Tsuchiya Y, et al. Expression of cell adhesion molecules in the lungs of patients with idiopathic pulmonary fibrosis.Chest, 1995,108:233-239.
3Drexler H, Kurz S, Jeserich M, et al. Effect of chronic angiotensin-converting enzyme inhibition on endothelial function in patients with chronic heart failure. Am J Cardiol, 1995,76:13E-18E.
5Kolls JK, Kanaly ST, Ramsay AJ. Interleukin-17: an emerging role in lung inflammation[J]. Am J Respir Cell Mol Biol, 2003, 28 (1): 9-11.
6Escotte S, Tabary O, Dusser D, et al. Fluticasone reduces IL-6 and IL-8 production of cystic fibrosis bronchial epithelial cells via IKK-beta ki-nase pathway [J]. Eur Respir J, 2003, 21 (4):574-581.
7Shen N, He B, Wang J, et al. Significance of anti interleukin-17 antibodies to air way inflammation in cigarettes smoke-induced COPD in mice [J]. Am J Respir Crit Care Med, 2009, 179 (1): A2955.
8Molet S, Hamid Q, Davoine F, et al. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cyt okines [J]. J Allergy Clin Immunol, 2001, 108 (3): 430-438.
9Inoshima I, Kuwano K, Hamada N, et al. Anti-monocyte chemoat-tractant protein -1 gene therapy attenuates pulmonary fi brosis in mice[J]. Am J Physiol Lung Cell Mol Physiol, 2004 86 (5):L1038-1044.
10Niehof M, Streetz K, Rakemann T, et al. Interleukin-6 in dueed tethering of STA T3 to the LA P/C/EBPβpromoter suggests a new mechanism of transcriptional regulation by STAT3[J].J Biol Chem, 2001, 276 (12): 9016-9027.
